AROmotion's Innovative Approach to Orthopedic Treatment
Addressing the Underlying Causes of Joint Pain with RFA
AROmotion addresses the underlying factors that result physiologically in chondromalacia and clinically as joint pain, swelling, and weakness. Once the joint has been deemed mechanically intact, Radiofrequency Ablation (RFA) is performed on the base of the sensory nerves affected by the chondromalacia. By disrupting the signal of pain transmitted by these nerves, the feedback loop of cytokine and interleukin activation is also stopped. Pain is not just a symptom; it is the root cause and instigator of joint degeneration.
Immediate Benefits and Long-term Effects of RFA
Within days of the RFA procedure, the volume of inflamed fluid inside the synovial joint capsule diminishes, and mobility improves. The nerves are disrupted for approximately one year, during which time a much more "normal" non-toxic joint environment is present. There is a secondary benefit of the RFA which is the immediate reconditioning of the muscles and ligaments that move the joint. This is because we have “turned off” the nerves that have been causing the joint pain and altering their gait to a shuffle versus normal walking heel-to-toe.
Strategic Use of RFA in AROmotion’s Treatment Approach
AROmotion uses RFA not only to stop the pain but more importantly, to turn off the production of Substance-P, the neuropeptide responsible for the inflammation or arthritis occurring inside the joint. AROmotion is using RFA to turn off the “pain-inflammation feedback loop,” clinically known as knee osteoarthritis, to provide a healthier, calmer joint environment for various Orthobiologics to help promote healing.
Enhancing Orthobiologic Treatments with RFA
The current use of Orthobiologics is mainly by Orthopedic Surgeons as a “last ditch” effort to help with knee pain. It typically fails because the fragile Orthobiologic is placed in an angry, inflamed OA knee joint environment resulting in rapid degradation. RFA stops Substance-P, the key neuropeptide causing the OA inflammation inside the joint. Placing the hyaluronic acid or any other Orthobiologic in this now calmed, less toxic, joint environment allows for its maximum effect. AROmotion is the only group in the U.S. that combines the RFA with hyaluronic acid or other Orthobiologics to create an augmented environment for healing.